Age and apoE associations with complex pathologic features in Alzheimer's disease

Journal of the Neurological Sciences

Volumn 273, Issue 1-2, 2008, Pages 34-39

  Jicha, Gregory A ^a   Parisi, Joseph E ^a   Dickson, Dennis W ^a,b   Cha, Ruth H ^a   Johnson, Kris A ^a   Smith, Glenn E ^a   Boeve, Bradley F ^a   Petersen, Ronald C ^a   Knopman, David S ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

age; Alzheimer's disease; Apolipoprotein E; Argyrophilic grains; Cerebrovascular disease; Lewy body disease

Indexed keywords

APOLIPOPROTEIN E;

AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; HUMAN; MICROANGIOPATHY; PRIORITY JOURNAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CEREBRAL AMYLOID ANGIOPATHY; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; LEWY BODY DISEASE; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES;

EID: 50249100253     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.06.008     Document Type: Article

References (65)

1. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 4 Suppl (1997) S1-2
2. Diagnostic and statistical manual of mental disorders. Third Edition (1987), American Psychiatric Association, Washington, D.C. Revised ed
3. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357 9251 (2001) 169-175
4. Alexianu M., Tudorache B., and Podani M. The importance of cerebral lesions of vascular origin in the morphopathologic picture of old age dementia. Neurol Psychiatr (Bucur) 27 2 (1989) 133-145
5. Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA, et al. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology in press.
6. Ashford J.W. APOE genotype effects on Alzheimer's disease onset and epidemiology. J Mol Neurosci 23 3 (2004) 157-165
7. Bennett D.A., Schneider J.A., Arvanitakis Z., Kelly J.F., Aggarwal N.T., Shah R.C., et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66 12 (2006) 1837-1844
8. Boeve B., McCormick J., Smith G., Ferman T., Rummans T., Carpenter T., et al. Mild cognitive impairment in the oldest old. Neurology 60 3 (2003) 477-480
9. Braak H., and Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 15 1 (1989) 13-26
10. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82 4 (1991) 239-259
11. Brayne C., Gill C., Huppert F.A., Barkley C., Gehlhaar E., Girling D.M., et al. Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord 9 3 (1998) 175-180
12. Bronge L., Bogdanovic N., and Wahlund L.O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement Geriatr Cogn Disord 13 4 (2002) 205-212
13. Brown D.F., Dababo M.A., Bigio E.H., Risser R.C., Eagan K.P., Hladik C.L., et al. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 57 1 (1998) 39-46
14. Casserly I., and Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet 363 9415 (2004) 1139-1146
15. de la Torre J.C. Alzheimer's disease is a vasocognopathy: a new term to describe its nature. Neurol Res 26 5 (2004) 517-524
16. Engelberg H. Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial. Dement Geriatr Cogn Disord 18 3-4 (2004) 278-298
17. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 9 Suppl 1 (1998) 6-12
18. Feigin V.L., Lawes C.M., Bennett D.A., and Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 1 (2003) 43-53
19. Fernando M.S., and Ince P.G. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 226 1-2 (2004) 13-17
20. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 3 (1975) 189-198
21. Fujino Y., Wang D.S., Thomas N., Espinoza M., Davies P., and Dickson D.W. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry. J Neuropathol Exp Neurol 64 3 (2005) 209-214
22. Galasko D., Saitoh T., Xia Y., Thal L.J., Katzman R., Hill L.R., et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 44 10 (1994) 1950-1951
23. Gearing M., Mirra S.S., Hedreen J.C., Sumi S.M., Hansen L.A., and Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology 45 3 Pt 1 (1995) 461-466
24. Gearing M., Schneider J.A., Rebeck G.W., Hyman B.T., and Mirra S.S. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 45 11 (1995) 1985-1990
25. Giannakopoulos P., Gold G., Kovari E., von Gunten A., Imhof A., Bouras C., et al. Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience. Acta Neuropathol 113 1 (2007) 1-12
26. Hansen L., Salmon D., Galasko D., Masliah E., Katzman R., DeTeresa R., et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40 1 (1990) 1-8
27. Humphries S.E., and Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol 3 4 (2004) 227-235
28. Jellinger K.A. Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111 10-11 (2004) 1219-1235
29. Jellinger K.A. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 5 3-4 (2008) 118-121
30. Jorm A.F., and Jolley D. The incidence of dementia: a meta-analysis. Neurology 51 3 (1998) 728-733
31. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol 42 11 (1985) 1097-1105
32. Knopman D.S., Parisi J.E., Boeve B.F., Cha R.H., Apaydin H., Salviati A., et al. Vascular dementia in a population-based autopsy study. Arch Neurol 60 4 (2003) 569-575
33. Kukull W.A., and Bowen J.D. Dementia epidemiology. Med Clin North Am 86 3 (2002) 573-590
34. Lim A., Tsuang D., Kukull W., Nochlin D., Leverenz J., McCormick W., et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 47 5 (1999) 564-569
35. Mastaglia F.L., Byrnes M.L., Johnsen R.D., and Kakulas B.A. Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: a postmortem study. J Clin Neurosci 10 2 (2003) 186-189
36. McKeith I.G. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9 3 Suppl (2006) 417-423
37. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 5 (1996) 1113-1124
38. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
39. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 4 (1991) 479-486
40. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 11 (1993) 2412-2414
41. Morris J.C., and Price A.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 17 2 (2001) 101-118
42. Napoli C., and Palinski W. Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis. Neurobiol Aging 26 3 (2005) 293-302
43. Olichney J.M., Hansen L.A., Galasko D., Saitoh T., Hofstetter C.R., Katzman R., et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47 1 (1996) 190-196
44. Parkkinen L., Kauppinen T., Pirttila T., Autere J.M., and Alafuzoff I. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57 1 (2005) 82-91
45. Parkkinen L., Pirttila T., and Alafuzoff I. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115 4 (2008) 399-407
46. Pasternak R.C., Criqui M.H., Benjamin E.J., Fowkes F.G., Isselbacher E.M., McCullough P.A., et al. Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology. Circulation 109 21 (2004) 2605-2612
47. Petersen R.C., Kokmen E., Tangalos E., Ivnik R.J., and Kurland L.T. Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano) 2 4 (1990) 408-415
48. Petersen R.C., Smith G.E., Ivnik R.J., Tangalos E.G., Schaid D.J., Thibodeau S.N., et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273 16 (1995) 1274-1278
49. Petrovitch H., White L.R., Ross G.W., Steinhorn S.C., Li C.Y., Masaki K.H., et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 57 2 (2001) 226-234
50. Rahkonen T., Eloniemi-Sulkava U., Rissanen S., Vatanen A., Viramo P., and Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74 6 (2003) 720-724
51. Saito Y., Kawashima A., Ruberu N.N., Fujiwara H., Koyama S., Sawabe M., et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. J Neuropathol Exp Neurol 62 6 (2003) 644-654
52. Saito Y., Ruberu N.N., Sawabe M., Arai T., Kazama H., Hosoi T., et al. Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 63 7 (2004) 742-749
53. Saito Y., Ruberu N.N., Sawabe M., Arai T., Tanaka N., Kakuta Y., et al. Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63 9 (2004) 911-918
54. Schneider J.A., Arvanitakis Z., Bang W., and Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69 24 (2007) 2197-2204
55. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., and Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277 10 (1997) 813-817
56. Togo T., Sahara N., Yen S.H., Cookson N., Ishizawa T., Hutton M., et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 61 6 (2002) 547-556
57. Tolnay M., and Clavaguera F. Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies. Neuropathology 24 4 (2004) 269-283
58. Troncoso J.C., Martin L.J., Dal Forno G., and Kawas C.H. Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. Neurobiol Aging 17 3 (1996) 365-371
59. Tsuang D.W., Wilson R.K., Lopez O.L., Luedecking-Zimmer E.K., Leverenz J.B., DeKosky S.T., et al. Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease. Neurology 64 3 (2005) 509-513
60. Wakisaka Y., Furuta A., Tanizaki Y., Kiyohara Y., Iida M., and Iwaki T. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol (Berl) 106 4 (2003) 374-382
61. Weller R.O., Cohen N.R., and Nicoll J.A. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. Panminerva Med 46 4 (2004) 239-251
62. Yamada M. Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 977 (2002) 37-44
63. Zekry D., Duyckaerts C., Belmin J., Geoffre C., Moulias R., and Hauw J.J. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J Neurol 249 11 (2002) 1529-1534
64. Zekry D., Hauw J.J., and Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 50 8 (2002) 1431-1438
65. Zhu L., Fratiglioni L., Guo Z., Winblad B., and Viitanen M. Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology 54 11 (2000) 2103-2107